Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Catenin signaling controls phrenic motor neuron development and function during a narrow temporal window.

Frontiers in neural circuits | 2023

Phrenic Motor Column (PMC) neurons are a specialized subset of motor neurons (MNs) that provide the only motor innervation to the diaphragm muscle and are therefore essential for survival. Despite their critical role, the mechanisms that control phrenic MN development and function are not well understood. Here, we show that catenin-mediated cadherin adhesive function is required for multiple aspects of phrenic MN development. Deletion of β- and γ-catenin from MN progenitors results in perinatal lethality and a severe reduction in phrenic MN bursting activity. In the absence of catenin signaling, phrenic MN topography is eroded, MN clustering is lost and phrenic axons and dendrites fail to grow appropriately. Despite the essential requirement for catenins in early phrenic MN development, they appear to be dispensable for phrenic MN maintenance, as catenin deletion from postmitotic MNs does not impact phrenic MN topography or function. Our data reveal a fundamental role for catenins in PMC development and suggest that distinct mechanisms are likely to control PMC maintenance.

Pubmed ID: 36895798 RIS Download

Associated grants

  • Agency: NICHD NIH HHS, United States
    Id: F30 HD096788
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS114510
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007250
  • Agency: NINDS NIH HHS, United States
    Id: F31 NS124240

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


α-Bungarotoxin, Alexa Fluor 555 conjugate (antibody)

RRID:AB_2617152

This unknown targets α-subunit of the nicotinic acetylcholine receptor (AChR) of neuromuscular junction

View all literature mentions

Synaptophysin Monoclonal Antibody (SP11) (antibody)

RRID:AB_10983675

This monoclonal targets Synaptophysin

View all literature mentions

Anti-Neurofilament L (antibody)

RRID:AB_887743

This polyclonal targets Neurofilament L

View all literature mentions

Oct-6 (C-20) (antibody)

RRID:AB_2268536

This polyclonal targets POU3F1

View all literature mentions

Non-phospho (Active) β-Catenin (Ser33/37/Thr41) (D13A1) Rabbit mAb (antibody)

RRID:AB_11127203

This unknown targets Non-phospho (Active) β-Catenin (Ser33/37/Thr41) (D13A1) Rabbit mAb

View all literature mentions

Anti-Olig2, clone 211F1.1, Alexa Fluor 488 Conjugate (antibody)

RRID:AB_11205039

This unknown targets Olig2 clone 211F1.1 Alexa Fluor 488 Conjugate

View all literature mentions

Cleaved Caspase-3 (Asp175) Antibody (antibody)

RRID:AB_2341188

This polyclonal targets Cleaved Caspase-3 (Asp175)

View all literature mentions